Qyuns Therapeutics buys back 253,200 H-shares for HK$3.83 million, trimming free float by 0.11%

Bulletin Express06-05 20:43

On 5 June 2026, Qyuns Therapeutics Co., Ltd. executed an on-market repurchase of 253,200 H-shares, paying a total of HK$3.83 million. The shares were repurchased at prices ranging from HK$14.64 to HK$15.80, with a volume-weighted average cost of HK$15.11 per share.

Following the transaction: • Issued shares (excluding treasury shares) decreased to 223.75 million from 224.00 million, a reduction of 0.11%. • Treasury shares rose to 3.32 million from 3.07 million, keeping total issued shares unchanged at 227.07 million.

Repurchase mandate status: • Authorised limit: 22.44 million shares. • Cumulative repurchases under the mandate: 616,600 shares, representing 0.27% of the company’s issued share capital on the mandate date (29 May 2026).

Under Hong Kong Listing Rules, Qyuns Therapeutics is restricted from issuing new shares or disposing of treasury shares until 5 July 2026. The company confirms that the buyback complied with all relevant Main Board requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1163215874?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 20:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163215874","market":"us","top_or_hot":-1,"title":"Qyuns Therapeutics buys back 253,200 H-shares for HK$3.83 million, trimming free float by 0.11%","media":"Bulletin Express","content":"<p>On 5 June 2026, Qyuns Therapeutics Co., Ltd. executed an on-market repurchase of 253,200 H-shares, paying a total of HK$3.83 million. The shares were repurchased at prices ranging from HK$14.64 to HK$15.80, with a volume-weighted average cost of HK$15.11 per share.</p>\n<p>Following the transaction:\n• Issued shares (excluding treasury shares) decreased to 223.75 million from 224.00 million, a reduction of 0.11%.  \n• Treasury shares rose to 3.32 million from 3.07 million, keeping total issued shares unchanged at 227.07 million.</p>\n<p>Repurchase mandate status:\n• Authorised limit: 22.44 million shares.  \n• Cumulative repurchases under the mandate: 616,600 shares, representing 0.27% of the company’s issued share capital on the mandate date (29 May 2026).</p>\n<p>Under Hong Kong Listing Rules, Qyuns Therapeutics is restricted from issuing new shares or disposing of treasury shares until 5 July 2026. The company confirms that the buyback complied with all relevant Main Board requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qyuns Therapeutics buys back 253,200 H-shares for HK$3.83 million, trimming free float by 0.11%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQyuns Therapeutics buys back 253,200 H-shares for HK$3.83 million, trimming free float by 0.11%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-05 20:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 5 June 2026, Qyuns Therapeutics Co., Ltd. executed an on-market repurchase of 253,200 H-shares, paying a total of HK$3.83 million. The shares were repurchased at prices ranging from HK$14.64 to HK$15.80, with a volume-weighted average cost of HK$15.11 per share.</p>\n<p>Following the transaction:\n• Issued shares (excluding treasury shares) decreased to 223.75 million from 224.00 million, a reduction of 0.11%.  \n• Treasury shares rose to 3.32 million from 3.07 million, keeping total issued shares unchanged at 227.07 million.</p>\n<p>Repurchase mandate status:\n• Authorised limit: 22.44 million shares.  \n• Cumulative repurchases under the mandate: 616,600 shares, representing 0.27% of the company’s issued share capital on the mandate date (29 May 2026).</p>\n<p>Under Hong Kong Listing Rules, Qyuns Therapeutics is restricted from issuing new shares or disposing of treasury shares until 5 July 2026. The company confirms that the buyback complied with all relevant Main Board requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02509","symbol_name":"荃信生物-B","start_time":0,"source_url":"","article_id":"1163215874","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163215874","pubTimestamp":1780663438,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 5 June 2026, Qyuns Therapeutics Co., Ltd. executed an on-market repurchase of 253,200 H-shares, paying a total of HK$3.83 million. The shares were repurchased at prices ranging from HK$14.64 to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02509":"荃信生物-B"},"translate_title":"Qyuns Therapeutics以383万港元回购25.32万股H股自由流通量削减0.11%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":1},"content_text":"On 5 June 2026, Qyuns Therapeutics Co., Ltd. executed an on-market repurchase of 253,200 H-shares, paying a total of HK$3.83 million. The shares were repurchased at prices ranging from HK$14.64 to HK$15.80, with a volume-weighted average cost of HK$15.11 per share.\nFollowing the transaction:\n• Issued shares (excluding treasury shares) decreased to 223.75 million from 224.00 million, a reduction of 0.11%.  \n• Treasury shares rose to 3.32 million from 3.07 million, keeping total issued shares unchanged at 227.07 million.\nRepurchase mandate status:\n• Authorised limit: 22.44 million shares.  \n• Cumulative repurchases under the mandate: 616,600 shares, representing 0.27% of the company’s issued share capital on the mandate date (29 May 2026).\nUnder Hong Kong Listing Rules, Qyuns Therapeutics is restricted from issuing new shares or disposing of treasury shares until 5 July 2026. The company confirms that the buyback complied with all relevant Main Board requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1163215874","isCrawlerRequest":true}